We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
-5.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$27.8M
(-10%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-4.59%
Top 10 Holdings %
Top 10 Hldgs %
37.51%
Holding
109
New
14
Increased
27
Reduced
32
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$7.67M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$5.23M |
| 3 |
Pfizer
PFE
|
+$4.48M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$3.65M |
| 5 |
GSK
GSK
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$9.89M |
| 2 |
AET
Aetna Inc
AET
|
+$5.01M |
| 3 |
AGN
Allergan plc
AGN
|
+$4.99M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$4.37M |
| 5 |
VWR
VWR Corporation
VWR
|
+$3.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.52% |
| 2 | Financials | 2.14% |
| 3 | Energy | 0% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $16M | 6.63% |
94,146
-1,400
| -1% | -$248K |
|
2
Encompass Health
EHC
$11B
| $9.87M | 4.08% |
300,931
-4,148
| -1% | -$135K |
|
|
STJ
3
DELISTED
St Jude Medical
STJ
| $9.69M | 4% |
120,777
+11,729
| +11% | +$931K |
|
4
Abbott
ABT
$183B
| $8.93M | 3.69% |
232,449
-14,159
| -6% | -$561K |
|
5
UnitedHealth
UNH
$376B
| $8.51M | 3.52% |
53,156
-5,900
| -10% | -$881K |
|
|
HOLX
6
DELISTED
Hologic
HOLX
| $8.02M | 3.31% |
199,958
-22,600
| -10% | -$872K |
|
|
7
Becton Dickinson
BDX
$45.6B
| $7.78M | 3.22% |
48,175
+46,227
| +2,373% | +$7.67M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $7.71M | 3.19% |
36,716
-24,084
| -40% | -$4.99M |
|
9
Boston Scientific
BSX
$69.5B
| $7.18M | 2.97% |
332,198
+73,900
| +29% | +$1.61M |
|
10
Stryker
SYK
$125B
| $7.05M | 2.91% |
58,815
-12,850
| -18% | -$1.48M |
|
|
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
| $6.62M | 2.73% |
79,964
-16,500
| -17% | -$1.36M |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $6.61M | 2.73% |
96,127
+19,300
| +25% | +$1.38M |
|
13
Cencora
COR
$60.6B
| $6.53M | 2.7% |
83,540
+13,575
| +19% | +$1.06M |
|
|
HRC
14
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $6.25M | 2.58% |
111,335
+92,135
| +480% | +$5.23M |
|
15
McKesson
MCK
$100B
| $6.08M | 2.51% |
43,272
-3,000
| -6% | -$441K |
|
|
BCR
16
DELISTED
CR Bard Inc.
BCR
| $5.53M | 2.29% |
24,627
+8,800
| +56% | +$1.91M |
|
17
DaVita
DVA
$15.4B
| $5.39M | 2.23% |
84,039
+4,700
| +6% | +$293K |
|
|
WMGI
18
DELISTED
Wright Medical Group Inc
WMGI
| $5.28M | 2.18% |
229,777
+40,199
| +21% | +$935K |
|
|
AET
19
DELISTED
Aetna Inc
AET
| $5.19M | 2.14% |
41,843
-41,822
| -50% | -$5.01M |
|
20
Thermo Fisher Scientific
TMO
$213B
| $5.15M | 2.13% |
36,486
+15,800
| +76% | +$2.33M |
|
|
MNK
21
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.94M | 2.04% |
99,128
-21,546
| -18% | -$1.27M |
|
|
22
Pfizer
PFE
$143B
| $4.52M | 1.87% |
+146,611
| New | +$4.48M |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $4.11M | 1.7% |
35,480
+2,000
| +6% | +$223K |
|
24
Elevance Health
ELV
$81.5B
| $4.04M | 1.67% |
28,100
+20,271
| +259% | +$2.71M |
|
25
CVS Health
CVS
$133B
| $3.67M | 1.52% |
46,500
+16,817
| +57% | +$1.36M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Endurant Capital Management held 109 positions worth $242M, down 10% from $270M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Endurant Capital Management withdrew a net $11.1M in Q4 2016, closing 36 positions and reducing 32 holdings. Its most notable exit was Amsurg Corp, an estimated $9.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Financials and Energy.
Against the trend, Endurant Capital Management opened a new position in Pfizer worth $4.52M.
- Endurant Capital Management's largest Q4 2016 buy was Pfizer: 146,611 shares worth $4.52M.
- Endurant Capital Management added most to Becton Dickinson in Q4 2016, an estimated $7.67M increase.
- Endurant Capital Management's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $5.01M.
- Endurant Capital Management fully exited Amsurg Corp in Q4 2016, selling an estimated $9.89M.
- Endurant Capital Management's ten largest holdings make up 38% of its $242M portfolio in Q4 2016.
- Endurant Capital Management opened 14 new positions and closed 36 in Q4 2016.
- Endurant Capital Management's portfolio value fell 10% quarter-over-quarter to $242M.
Based on Endurant Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.